Place of work
Ilkovičova 8, Bratislava
Contract type
full-time
Start date
ASAP
Wage (gross)
2 000 EUR/month
Salary increases by 10% after the trial period.
We are looking for a Junior Scientist to join our team in supporting internal and external cross functional teams as we deliver ground-breaking breast cancer diagnostics tools.
The Spatial Biology group is looking for an enthusiastic Molecular Biologist to perform immunohistology and RNA sequencing assays to validate a novel deep learning model for histopathological analysis of breast cancer tissue samples. You will have relevant technical skills and experience of molecular biology and laboratory procedures to perform standard histochemistry and molecular biology assays with appropriate guidance from colleagues and managers.
The position will be based at the headquarters in Bratislava, Slovakia located at the modern Comenius University Science Park.
Conduct and analyse standard laboratory assays supporting spatial transcriptomics studies in accordance with set timelines.
PerformRNA fluorescent in situ hybridization, immunohistochemistry and using fluorescence/brightfield microscopy and laser capture microdissection to image and dissect tissue.
Image acquisition of tissue sections and subsequent image analysis using available platforms and software.
Follow and write protocols and SOPs.
Keep accurate records and report scientific results.
Keep up to date with the scientific literature and developments in the field
We offer a great career with development opportunities in a highly motivating and professional environment. You may be looking for a new career path or simply looking to contribute to a small, hard-working organization with the ambition to make a difference.
You will be offered the opportunity to spearhead the next ground-breaking nucleic acid-based detection technologies and diagnostics which will make a difference in real-world clinical settings.
The job will be challenging and rewarding at the same time. You will have world class colleagues, 4-5 weeks of paid holiday, and a salary commensurate to your qualifications (starting from €2000/month).
Please send the application including your CV AND a cover letter to career@multiplexdx.com.
Your application will be treated in accordance with our policies for processing of personal data and the General Data Protection Regulation of the EU.
University education (Bachelor's degree)
University education (Master's degree)
Education in Biology, Molecular Biology, Biochemistry, Biotechnology, Pharmaceutical Sciences or related field
English - Advanced (C1)
MultiplexDX’s diagnostic products combine specific, precise, automated, high-throughput, multiplexed and quantitative RNA visualization and sequencing to come up with a specific “barcode” for each cancer, which suggests a unique, personalized treatment strategy. In MultiplexDX’s diagnostic tests, multiplexing stands for cross-validating test results by using two independent perspectives, visualization and sequencing. This multiplexed platform provides the most accurate clinical parameters of a patient’s cancer profile, which enables an oncologist to make an evidence-based decision and target treatment quickly, directly, and more accurately.
Please send the application including your CV or resume with the names of 2 references and a cover letter to career@multiplexdx.com.
Your application will be treated in accordance with our policies for processing of personal data and the General Data Protection Regulation of the EU.
Marcel Kasanický
+421290268316
Ilkovičova 8
84104 Bratislava, Slovakia
career@multiplexdx.com
www.multiplexdx.com
MultiplexDX is one of the most innovative biotech corporations, created to bring its revolutionary technologies to the market of personalized molecular diagnostics. The company has representation in both U.S. and European markets. The collaborators of MultiplexDX are from the world’s most prestigious scientific organizations including the National Cancer Institute, Rockefeller University, Albert Einstein University, Vanderbilt University, Cornell University, Queens University (Canada), Hebrew University of Jerusalem (Israel), and the Max Delbrück Center for Molecular Medicine (Germany).
MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining MDX proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient which allows clinicians to suggest specific, personalized cancer treatment.
Find out more about MultiplexDX on Corporate website, Facebook, LinkedIn, Twitter